Wolverine Trading, LLC Acadia Pharmaceuticals Inc Transaction History
Wolverine Trading, LLC
- $93.9 Billion
- Q3 2024
A detailed history of Wolverine Trading, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 15,700 shares of ACAD stock, worth $288,409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,700Holding current value
$288,409% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding ACAD
# of Institutions
284Shares Held
158MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$788 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$254 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$252 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$222 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$110 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.97B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...